124 related articles for article (PubMed ID: 33527533)
1. T-cell receptors provide potential prognostic signatures for breast cancer.
Liu J; Zhang J
Cell Biol Int; 2021 Jun; 45(6):1220-1230. PubMed ID: 33527533
[TBL] [Abstract][Full Text] [Related]
2. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
[TBL] [Abstract][Full Text] [Related]
4. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer.
He M; Hu C; Deng J; Ji H; Tian W
World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547
[TBL] [Abstract][Full Text] [Related]
6. A novel circadian cycle-related gene signature for prognosis prediction of patients with breast cancer.
Hu Y; Fan S; Zhu Y; Xie X
Medicine (Baltimore); 2023 May; 102(18):e33718. PubMed ID: 37144994
[TBL] [Abstract][Full Text] [Related]
7. Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer.
Ren X; Cui H; Wu J; Zhou R; Wang N; Liu D; Xie X; Zhang H; Liu D; Ma X; Dang C; Kang H; Lin S
Cancer Med; 2022 Oct; 11(20):3886-3901. PubMed ID: 35441810
[TBL] [Abstract][Full Text] [Related]
8. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
[No Abstract] [Full Text] [Related]
9. Human nuclear receptors (NRs) genes have prognostic significance in hepatocellular carcinoma patients.
Sun G; Sun K; Shen C
World J Surg Oncol; 2021 Apr; 19(1):137. PubMed ID: 33941198
[TBL] [Abstract][Full Text] [Related]
10. Construction and Analysis of a Mitochondrial Metabolism-Related Prognostic Model for Breast Cancer to Evaluate Survival and Immunotherapy.
Lin Y; Huang Z; Zhang B; Yang H; Yang S
J Membr Biol; 2024 Apr; 257(1-2):63-78. PubMed ID: 38441572
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis to screen key prognostic genes in the breast cancer tumor microenvironment.
Ye Q; Han X; Wu Z
Bioengineered; 2020 Dec; 11(1):1280-1300. PubMed ID: 33164640
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel cell glycolysis related gene signature predicting survival in patients with breast cancer.
Jiang F; Wu C; Wang M; Wei K; Wang J
Sci Rep; 2021 Feb; 11(1):3986. PubMed ID: 33597614
[TBL] [Abstract][Full Text] [Related]
13. A Novel Gene Prognostic Signature Based on Differential DNA Methylation in Breast Cancer.
Zhu C; Zhang S; Liu D; Wang Q; Yang N; Zheng Z; Wu Q; Zhou Y
Front Genet; 2021; 12():742578. PubMed ID: 34956313
[No Abstract] [Full Text] [Related]
14. A prognostic index based on a fourteen long non-coding RNA signature to predict the recurrence-free survival for muscle-invasive bladder cancer patients.
Zhang X; Zhang M; Zhang X; Zhu X; Wang J
BMC Med Inform Decis Mak; 2020 Jul; 20(Suppl 3):136. PubMed ID: 32646427
[TBL] [Abstract][Full Text] [Related]
15. Development of a prognostic signature based on immune-related genes and the correlation with immune microenvironment in breast cancer.
Dong M; Cui X; Wang G; Zhang Q; Li X
Aging (Albany NY); 2022 Jul; 14(13):5427-5448. PubMed ID: 35793235
[TBL] [Abstract][Full Text] [Related]
16. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
17. A novel immune-related prognostic index for predicting breast cancer overall survival.
Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
[TBL] [Abstract][Full Text] [Related]
18. A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs.
Huang Z; Xiao C; Zhang F; Zhou Z; Yu L; Ye C; Huang W; Li N
Front Genet; 2020; 11():634195. PubMed ID: 33584821
[No Abstract] [Full Text] [Related]
19. Development of a breast cancer prognostic model based on vesicle-mediated transport-related genes to predict immune landscape and clinical drug therapy.
Zhu X; Wang F; Wang M; Lv L; Fang L; Song J; Wang X; Ding F
Hum Mol Genet; 2024 Mar; 33(7):553-562. PubMed ID: 38129105
[TBL] [Abstract][Full Text] [Related]
20. A Novel Pyroptosis-Associated Long Non-coding RNA Signature Predicts Prognosis and Tumor Immune Microenvironment of Patients With Breast Cancer.
Ping L; Zhang K; Ou X; Qiu X; Xiao X
Front Cell Dev Biol; 2021; 9():727183. PubMed ID: 34616734
[No Abstract] [Full Text] [Related]
[Next] [New Search]